High-resolution detection and mapping of genomic DNA alterations in neuroblastoma (Q40423034)

20 September 2017

High-resolution detection and mapping of genomic DNA alterations in neuroblastoma (English)

1 reference

20 September 2017

3

Adam Margolin

1 reference

20 September 2017

Yael P Mosse

1

1 reference

20 September 2017

Joel Greshock

2

1 reference

20 September 2017

Tara Naylor

4

1 reference

20 September 2017

Kristina Cole

5

1 reference

20 September 2017

Deepa Khazi

6

1 reference

20 September 2017

George Hii

7

1 reference

20 September 2017

Cynthia Winter

8

1 reference

20 September 2017

Syed Shahzad

9

1 reference

20 September 2017

Muhammad Usman Asziz

10

1 reference

20 September 2017

Jaclyn A Biegel

11

1 reference

20 September 2017

Barbara L Weber

12

1 reference

20 September 2017

John M Maris

13

1 reference

20 September 2017

language of work or name

1 reference

1 August 2005

1 reference

Genes, Chromosomes and Cancer

20 September 2017

1 reference

20 September 2017

43

1 reference

20 September 2017

4

1 reference

20 September 2017

390-403

1 reference

Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.

20 September 2017

1 reference

Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas

21 January 2018

1 reference

Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene

21 January 2018

1 reference

Genomic microarrays in human genetic disease and cancer

21 January 2018

1 reference

7 January 2021

Chromosome aberrations in solid tumors

1 reference

7 January 2021

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

7 January 2021

Neuroblastoma: biological insights into a clinical enigma

1 reference

7 January 2021

cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma

1 reference

7 January 2021

Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma

1 reference

7 January 2021

Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay.

1 reference

7 January 2021

1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis

1 reference

7 January 2021

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas

1 reference

7 January 2021

Correlating telomerase activity levels with human neuroblastoma outcomes

1 reference

7 January 2021

Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?

1 reference

7 January 2021

Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas

1 reference

7 January 2021

Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas

1 reference

7 January 2021

A tiling resolution DNA microarray with complete coverage of the human genome

1 reference

7 January 2021

Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival

1 reference

7 January 2021

The homeobox gene MEIS1 is amplified in IMR-32 and highly expressed in other neuroblastoma cell lines

1 reference

7 January 2021

Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors

1 reference

7 January 2021

Molecular biology of neuroblastoma

1 reference

7 January 2021

Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study

1 reference

7 January 2021

Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma

1 reference

7 January 2021

Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction

1 reference

7 January 2021

Germline PHOX2B mutation in hereditary neuroblastoma

1 reference

7 January 2021

Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line

1 reference

7 January 2021

Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma

1 reference

7 January 2021

Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues

1 reference

7 January 2021

Variety and complexity of chromosome 17 translocations in neuroblastoma

1 reference

7 January 2021

Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study

1 reference

7 January 2021

The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32

1 reference

7 January 2021

Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma

1 reference

7 January 2021

Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP.

1 reference

7 January 2021

Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?

1 reference

7 January 2021

High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization

1 reference

7 January 2021

Cancer genes and the pathways they control

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20198

1 reference

20 September 2017

1 reference